Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction
Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has announced a strategic debt-to-equity exchange transaction with Madryn Asset Management. The company exchanged $6.5 million of its subordinated convertible notes for 325,651 shares of Series Y preferred stock.
Following this transaction, Venus Concept's total debt obligations decreased to $34.3 million, representing a 14% reduction compared to the $39.7 million outstanding as of December 31, 2024. The company is currently working on completing its previously announced divestiture of the Venus Hair business while focusing on achieving sustained long-term growth and profitability.
Venus Concept (NASDAQ: VERO), leader globale nella tecnologia estetica medica, ha annunciato una transazione strategica di conversione del debito in capitale azionario con Madryn Asset Management. L'azienda ha convertito 6,5 milioni di dollari dei suoi titoli convertibili subordinati in 325.651 azioni di azioni privilegiate Serie Y.
A seguito di questa operazione, l'indebitamento totale di Venus Concept 猫 sceso a 34,3 milioni di dollari, con una riduzione del 14% rispetto ai 39,7 milioni di dollari in essere al 31 dicembre 2024. L'azienda sta attualmente lavorando per completare la cessione precedentemente annunciata del business Venus Hair, concentrandosi nel contempo sul raggiungimento di una crescita sostenuta e profitti a lungo termine.
Venus Concept (NASDAQ: VERO), l铆der global en tecnolog铆a est茅tica m茅dica, ha anunciado una transacci贸n estrat茅gica de conversi贸n de deuda a capital con Madryn Asset Management. La compa帽铆a intercambi贸 6,5 millones de d贸lares de sus notas convertibles subordinadas por 325.651 acciones de acciones preferentes Serie Y.
Tras esta transacci贸n, las obligaciones totales de deuda de Venus Concept se redujeron a 34,3 millones de d贸lares, lo que representa una reducci贸n del 14% en comparaci贸n con los 39,7 millones pendientes al 31 de diciembre de 2024. La empresa est谩 trabajando actualmente para completar la venta previamente anunciada del negocio Venus Hair, mientras se enfoca en lograr un crecimiento sostenible y rentabilidad a largo plazo.
Venus Concept (NASDAQ: VERO)電� 旮�搿滊矊 鞚橂 氙胳毄 旮办垹 靹犽弰 旮办梾鞙茧, Madryn Asset Management鞕� 鞝勲灥鞝� 攵�毂勲ゼ 欤检嫕鞙茧 鞝勴櫂頃橂姅 瓯半灅毳� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 650毵� 雼煬 靸侂嫻鞚� 頉勳垳鞙� 鞝勴櫂 靷眲毳� 325,651欤�鞚� Y 鞁滊Μ歃� 鞖办劆欤茧 甑愴櫂頄堨姷雼堧嫟.
鞚措矆 瓯半灅毳� 韱淀暣 Venus Concept鞚� 齑� 攵�毂勲姅 3430毵� 雼煬搿� 臧愳唽頄堨溂氅�, 鞚措姅 2024雲� 12鞗� 31鞚� 旮办 氙胳儊頇� 攵�毂� 3970毵� 雼煬鞐愳劀 14% 臧愳唽頃� 靾橃箻鞛呺媹雼�. 須岇偓電� 順勳灛 鞚挫爠鞐� 氚滍憸頃� Venus Hair 靷梾 毵り皝鞚� 鞕勲頃橂姅 霃欖嫓鞐� 歆�靻� 臧�電ロ暅 鞛リ赴 靹膘灔瓿� 靾橃澋靹� 雼劚鞐� 歆戩頃橁碃 鞛堨姷雼堧嫟.
Venus Concept (NASDAQ : VERO), leader mondial des technologies esth茅tiques m茅dicales, a annonc茅 une transaction strat茅gique de conversion de dette en actions avec Madryn Asset Management. La soci茅t茅 a 茅chang茅 6,5 millions de dollars de ses billets convertibles subordonn茅s contre 325 651 actions d鈥檃ctions privil茅gi茅es de la s茅rie Y.
脌 la suite de cette transaction, les obligations totales de dette de Venus Concept ont diminu茅 脿 34,3 millions de dollars, soit une r茅duction de 14 % par rapport aux 39,7 millions de dollars en circulation au 31 d茅cembre 2024. La soci茅t茅 travaille actuellement 脿 finaliser la cession pr茅c茅demment annonc茅e de l鈥檃ctivit茅 Venus Hair, tout en se concentrant sur la r茅alisation d鈥檜ne croissance durable et d鈥檜ne rentabilit茅 脿 long terme.
Venus Concept (NASDAQ: VERO), ein weltweit f眉hrendes Unternehmen im Bereich medizinischer 盲sthetischer Technologien, hat eine strategische Schulden-zu-Eigenkapital-Transaktion mit Madryn Asset Management angek眉ndigt. Das Unternehmen tauschte 6,5 Millionen US-Dollar seiner nachrangigen wandelbaren Schuldverschreibungen gegen 325.651 Aktien der Vorzugsaktien der Serie Y ein.
Nach dieser Transaktion verringerte sich die Gesamtverschuldung von Venus Concept auf 34,3 Millionen US-Dollar, was eine 14%ige Reduzierung gegen眉ber den ausstehenden 39,7 Millionen US-Dollar zum 31. Dezember 2024 darstellt. Das Unternehmen arbeitet derzeit an der Fertigstellung des zuvor angek眉ndigten Verkaufs des Gesch盲ftsbereichs Venus Hair, w盲hrend es sich auf nachhaltiges langfristiges Wachstum und Profitabilit盲t konzentriert.
- Reduced total debt obligations by 14% from $39.7M to $34.3M
- Strategic partnership with Madryn Asset Management provides financial flexibility
- Progress towards optimization of capital structure
- Company still carries significant debt of $34.3M
- Debt-to-equity exchange results in potential dilution through issuance of preferred stock
Insights
Venus Concept reduced debt by 14% through a $6.5M debt-to-equity exchange, improving its balance sheet while working toward business transformation.
Venus Concept has executed a strategic $6.5 million debt-to-equity exchange with Madryn Asset Management, converting subordinated notes into 325,651 shares of Series Y preferred stock. This transaction has reduced the company's total debt obligations from $39.7 million to approximately $34.3 million - a
This exchange represents a meaningful balance sheet improvement that provides Venus Concept with enhanced financial flexibility as they work through two critical strategic initiatives: 1) completing their previously announced divestiture of the Venus Hair business, and 2) pursuing their broader transformation plan aimed at returning to sustainable growth and profitability.
The continued support from Madryn, as evidenced by their willingness to exchange debt for equity, signals confidence in management's strategic direction. This is the latest in what appears to be an ongoing effort to optimize Venus Concept's capital structure. By reducing interest-bearing debt obligations and replacing them with preferred equity, the company is likely decreasing its regular cash outflows for debt service, which should improve future cash flow metrics.
The debt exchange helps address near-term balance sheet concerns but represents only part of Venus Concept's broader transformation journey. The company continues to work through significant business changes, including the pending Venus Hair business divestiture, as they navigate their path toward sustainable growth and profitability in the medical aesthetics technology sector.
Further reduction of outstanding debt by Madryn Asset Management improves the Company鈥檚 balance sheet position
TORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc.聽(鈥淰enus Concept鈥� or the 鈥淐ompany鈥�)聽(NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on聽June 30, 2025, the Company exchanged聽
鈥淲e continue to optimize our capital structure with the completion of an additional debt exchange that reduces our overall debt balance,鈥� said聽Rajiv De Silva, Chief Executive Officer of聽Venus Concept. 鈥淢adryn鈥檚 invaluable partnership has enabled us to have the financial flexibility to work on closing our previously announced divestiture of the Venus Hair business and continue our journey towards sustained long-term growth and profitability.鈥�
鈥淭oday鈥檚 debt-to-equity exchange builds on our relationship with Venus and enables the Company to continue through its transformation plan,鈥� said聽Avinash Amin, MD, Managing Partner at聽Madryn Asset Management, LP. 鈥淲e support the efforts by the Management team and look forward to the Company鈥檚 return to growth.鈥�
Cautionary Statement Regarding Forward-Looking Statements
This communication contains 鈥渇orward-looking statements鈥� statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained herein that are not of historical facts may be deemed to be forward-looking statements. In some cases, you can identify these statements by words such as such as 鈥渁nticipates,鈥� 鈥渂elieves,鈥� 鈥減lans,鈥� 鈥渆xpects,鈥� 鈥減rojects,鈥� 鈥渇uture,鈥� 鈥渋ntends,鈥� 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渃ould,鈥� 鈥渆stimates,鈥� 鈥減redicts,鈥� 鈥減otential,鈥� and other similar expressions that are predictions of or indicate future events and future trends. These forward-looking statements are based on current expectations, estimates, and projections about our business and the industry in which we operate, as well as management's beliefs and assumptions, and are not guarantees of future performance or developments and involve known and unknown risks, uncertainties, and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this communication may turn out to be inaccurate. Factors that could materially affect our business operations and financial performance and condition include, but are not limited to, the Company鈥檚 ability to achieve its strategic goals and return to profitability, as well as those risks and uncertainties described under Part I Item 1A鈥斺�淩isk Factors鈥� in our Annual Report on Form 10-K for the fiscal year ended聽December 31, 2024, Part II Item 1A鈥斺�淩isk Factors鈥� in our most recent Form 10-Q and in other documents we may file with the SEC. Readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on the forward-looking statements. The forward-looking statements are based on information available to us as of the date of this communication. Unless required by law, we do not intend to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise.
About聽Venus Concept
Venus Concept聽is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets.聽Venus Concept's聽product portfolio consists of aesthetic device platforms, including聽Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva,聽Venus Glow,聽Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME.聽Venus Concept's聽hair restoration systems include NeoGraft庐 and the ARTAS iX庐 Robotic Hair Restoration system.聽Venus Concept聽has been backed by leading healthcare industry growth equity investors including聽EW Healthcare Partners聽(formerly聽Essex Woodlands),聽HealthQuest Capital,聽Longitude Capital Management,聽Aperture Venture Partners, Masters Special Situations, and聽Madryn Asset Management, L.P.
Investor Relations Contact: ICR Healthcare on behalf of Venus Concept: Mike Piccinino, CFA [email protected]
FAQ
What is the value of Venus Concept's (VERO) debt exchange transaction in 2025?
How much did Venus Concept (VERO) reduce its total debt in the 2025 transaction?
What is Venus Concept's (VERO) remaining debt after the 2025 exchange?
How many preferred shares did Venus Concept (VERO) issue in the debt exchange?
What is Venus Concept's (VERO) strategic focus after the 2025 debt exchange?
